Related Experiment Video
Updated: May 23, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Persistent candidemia in a renal-pancreatic transplant patient]
Miguel Solla-Buceta1, Ana Hurtado-Doce, Luis Álvarez-Rocha
1Servicio de Medicina Intensiva, Complexo Hospitalario Universitario A Coruña, A Coruña, España.
Background:
In recent decades, there has been an increase in the survival of recipients of solid organ transplants related to the improvement of the surgical technique, the introduction of protocols for immunosuppressive therapy, and the use of antimicrobial prophylaxis. Nonetheless, invasive fungal infection (IFI) is currently the major cause of morbidity and mortality in this group of patients. Invasive candidiasis is the most common IFI found after renal transplantation and is usually associated with total parenteral nutrition, broad-spectrum antibiotic therapy and abdominal surgery.
Clinical Case:
We report the case of a recent kidney-pancreas transplant recipient who developed a persistent catheter-related candidemia caused by Candida glabrata. The patient was treated with anidulafungin and had a good clinical course with no significant drug interactions. We discuss the possible causes and diagnostic and therapeutic alternatives of this kind of infection.
Insights
Solid organ transplant recipients face high risks of invasive fungal infections (IFI). This case study highlights successful treatment of Candida glabrata candidemia in a kidney-pancreas transplant patient using anidulafungin.
Area of Science:
- Transplantation immunology
- Infectious diseases
- Clinical microbiology
Background:
- Solid organ transplantation survival has improved due to surgical advances, immunosuppression, and antimicrobial prophylaxis.
- Invasive fungal infections (IFI) remain a significant cause of morbidity and mortality in transplant recipients.
- Invasive candidiasis is the most frequent IFI post-renal transplantation, often linked to parenteral nutrition, antibiotics, and abdominal surgery.
Observation:
- A kidney-pancreas transplant recipient developed persistent catheter-related candidemia.
- The causative agent identified was Candida glabrata.
- The patient experienced a favorable clinical outcome.
Findings:
- Anidulafungin was effective in treating Candida glabrata candidemia.
- No significant drug interactions were observed during treatment.
- Catheter-related candidemia poses a challenge in immunocompromised transplant patients.
Implications:
- This case underscores the importance of vigilant monitoring for IFI in transplant recipients.
- Anidulafungin presents a viable treatment option for Candida glabrata infections with a good safety profile.
- Further research into diagnostic and therapeutic strategies for IFI in this population is warranted.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
